Table 4. Hazard ratios of 2-year event rates of clinical outcomes according to diabetes mellitus.
| Unadjusted | IPTW adjusted | ||||||
|---|---|---|---|---|---|---|---|
| Characteristics | Non-DM (n = 1308) | DM (n = 605) | P Value | Hazard Ratio (95% CI) | P Value | Hazard Ratio (95% CI) | P Value |
| MACE | 76 (6.2) | 75 (12.7) | <0.001 | 2.24 (1.63–3.08) | <0.001 | 2.07 (1.50–2.86) | <0.001 |
| Death from any cause | 23 (1.9) | 31 (5.2) | <0.001 | 2.97 (1.73–5.09) | <0.001 | 2.21 (1.27–3.83) | 0.005 |
| Cardiac death | 10 (0.8) | 17 (2.8) | <0.001 | 3.74 (1.71–8.17) | 0.001 | 2.42 (1.11–5.27) | 0.026 |
| Non-cardiac death | 13 (1.1) | 14 (2.5) | 0.021 | 2.37 (1.11–5.05) | 0.025 | 2.02 (0.92–4.40) | 0.078 |
| Myocardial infarction | 5 (0.4) | 10 (1.6) | 0.003 | 4.43 (1.51–12.95) | 0.007 | 4.71 (1.63–13.63) | 0.004 |
| Q wave MI | 2 (0.2) | 5 (0.7) | 0.022 | 5.51 (1.07–28.42) | 0.041 | 5.74 (1.15–28.57) | 0.033 |
| Non-Q wave MI | 3 (0.3) | 5 (0.9) | 0.055 | 3.70 (0.88–15.49) | 0.073 | 3.98 (0.96–16.61) | 0.058 |
| Repeat revascularization | 56 (4.6) | 47 (8.2) | <0.001 | 1.91 (1.30–2.81) | 0.001 | 2.07 (1.41–3.03) | <0.001 |
| Target vessel | 31 (2.6) | 27 (4.9) | <0.001 | 1.98 (1.18–3.31) | 0.010 | 1.94 (1.16–3.26) | 0.012 |
| Target lesion | 22 (3.9) | 19 (5.2) | 0.029 | 1.96 (1.06–3.62) | 0.032 | 1.81 (0.95–3.42) | 0.071 |
| Non-target vessel | 25 (2.1) | 20 (3.5) | 0.042 | 1.83 (1.01–3.29) | 0.045 | 2.22 (1.26–3.91) | 0.006 |
| Definite or probable stent thrombosis | 3 (0.2) | 3 (0.5) | 0.32 | 2.2 (0.44–10.91) | 0.33 | 2.52 (0.53–12.03) | 0.25 |
*Cumulative rates of events based on Kaplan-Meier estimates.
Abbreviations: DM, diabetes mellitus; CI, confidence interval; IPTW, inverse probability of treatment weighting; MACE, major adverse cardiac event; MI, myocardial infarction.